PT Kalbe Valuation
| PTKFF Stock | USD 0.09 0.00 0.00% |
PT Kalbe seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of PT Kalbe Farma from inspecting the company fundamentals such as shares owned by institutions of 15.23 %, and Return On Asset of 0.11 as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors support locking in undervalued equities and disposing overvalued equities since, at some future date, asset prices and their ongoing real values will converge.
Overvalued
Today
Please note that PT Kalbe's price fluctuation is out of control at this time. Calculation of the real value of PT Kalbe Farma is based on 3 months time horizon. Increasing PT Kalbe's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for PT Kalbe Farma is useful when determining the fair value of the PTKFF pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of PT Kalbe. Since PT Kalbe is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PTKFF Pink Sheet. However, PT Kalbe's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.09 | Real 0.0775 | Hype 0.09 |
The real value of PTKFF Pink Sheet, also known as its intrinsic value, is the underlying worth of PT Kalbe Farma Company, which is reflected in its stock price. It is based on PT Kalbe's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of PT Kalbe's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence PT Kalbe's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of PT Kalbe Farma helps investors to forecast how PTKFF pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PT Kalbe more accurately as focusing exclusively on PT Kalbe's fundamentals will not take into account other important factors: PT Kalbe Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining PT Kalbe's current stock value. Our valuation model uses many indicators to compare PT Kalbe value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PT Kalbe competition to find correlations between indicators driving PT Kalbe's intrinsic value. More Info.PT Kalbe Farma is considered to be number one stock in price to book category among related companies. It is considered to be number one stock in price to sales category among related companies fabricating about 0.69 of Price To Sales per Price To Book. The ratio of Price To Book to Price To Sales for PT Kalbe Farma is roughly 1.44 . Comparative valuation analysis is a catch-all model that can be used if you cannot value PT Kalbe by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for PT Kalbe's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PT Kalbe's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates PT Kalbe's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in PT Kalbe and how it compares across the competition.
About PT Kalbe Valuation
The pink sheet valuation mechanism determines the current worth of PT Kalbe Farma on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of PT Kalbe Farma. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of PT Kalbe Farma based exclusively on its fundamental and basic technical indicators. By analyzing PT Kalbe's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of PT Kalbe's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of PT Kalbe. We calculate exposure to PT Kalbe's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to PT Kalbe's related companies.PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia. PT Kalbe operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 12501 people.
8 Steps to conduct PT Kalbe's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates PT Kalbe's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct PT Kalbe's valuation analysis, follow these 8 steps:- Gather financial information: Obtain PT Kalbe's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine PT Kalbe's revenue streams: Identify PT Kalbe's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research PT Kalbe's industry and market trends, including the size of the market, growth rate, and competition.
- Establish PT Kalbe's growth potential: Evaluate PT Kalbe's management, business model, and growth potential.
- Determine PT Kalbe's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate PT Kalbe's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
A single share of PT Kalbe represents a small ownership stake in the entity. As a stockholder of PTKFF, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
PT Kalbe Dividends Analysis For Valuation
Please note that PT Kalbe has scaled down on payment of dividends at this time.
There are various types of dividends PT Kalbe can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of PTKFF shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from PT Kalbe Farma directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When PTKFF pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of PT Kalbe by the value of the dividends paid out.
PT Kalbe Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as PT Kalbe does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 46.9 B | |
| Quarterly Earnings Growth Y O Y | 0.087 | |
| Forward Price Earnings | 26.3158 | |
| Retained Earnings | 18.7 T |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PT Kalbe Farma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the PT Kalbe Farma information on this page should be used as a complementary analysis to other PT Kalbe's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for PTKFF Pink Sheet analysis
When running PT Kalbe's price analysis, check to measure PT Kalbe's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PT Kalbe is operating at the current time. Most of PT Kalbe's value examination focuses on studying past and present price action to predict the probability of PT Kalbe's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PT Kalbe's price. Additionally, you may evaluate how the addition of PT Kalbe to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |